Patent details
EP1482932 Title: N3 alkylated benzimidazole derivatives as MEK inhibitors.
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic Information
- Publication number:
- EP1482932
- WO Application Number:
- US2003007864
- Type:
- European Patent Granted for NL
- Status:
- Expired. Art. 36.6 ROW
- Publication Title:
- Title When Made Available For Viewing:
- Reason Lapsed:
- Application number:
- EP03714148.8
- WO Publication Number:
- WO2003077914
- EPO Publication Language:
- English
- SPC Number:
-
300974
- First Applicant Residence Country:
- United States of America (US)
- Publications:
Dates
- Filing date:
- 13/03/2003
- Grant date:
- 25/11/2009
- EP Publication Date:
- 25/11/2009
- WO Publication Date:
- Claims Translations Received Date:
- Claims Translation B1 Received Date:
- Claims Translation B2 Received Date:
- Claims Translation B3 Received Date:
- Lapsed By Non Payment Annual Fee Date:
- Renunciation Date:
- NullificationDate:
- Published:
- Due To Cession Date:
- Registration date:
- 25/11/2009
- EP B1 Publication Date:
- 25/11/2009
- EP B2 Publication Date:
- EP B3 Publication Date:
- Description Translation B1 Received Date:
- Description Translation B2 Received Date:
- Description Translation B3 Received Date:
- Expiration date:
- 12/03/2023
- Lapsed By Expiration Date:
- 13/03/2023
- Revocation Date:
- Invalidity Date:
- Response To Novelty Search Report Received:
- Patent Granting Request:
- Lapsed date:
Applicant/holder
- From:
- 28/06/2019
- Name:
- AstraZeneca AB
- Address:
- Västra Mälarehamnen 9, 15185, Södertälje, Sweden (SE)
- From:
- 28/06/2019
- Name:
- Array BioPharma Inc.
- Address:
- 3200 Walnut Street, 80301, Boulder, CO, United States of America (US)
Historical Applicant/holder
- From:
- 20/09/2016
- To:
- 28/06/2019
- Name:
- Array Biopharma, Inc.
- Address:
- 3200 Walnut Street, 80301, Boulder, Colorado, United States of America (US)
- From:
- 20/09/2016
- To:
- 28/06/2019
- Name:
- AstraZeneca AB
- Address:
- Västra Mälarehamnen 9, 15185, Södertälje, Sweden (SE)
- From:
- 25/11/2009
- To:
- 20/09/2016
- Name:
- Array Biopharma, Inc.
- Address:
- 3200 Walnut Street, 80301, Boulder, Colorado, United States of America (US)
Domicile Holder
- Name:
- ir. F.A. Geurts c.s.
- From:
- 25/11/2009
- Address:
- Octrooibureau Vriesendorp & Gaade B.V. Koninginnegracht 19, 2514 AB, Den Haag, Netherlands (NL)
- To:
Inventor
1
- Name:
- Eli, M. WALLACE
- Address:
- CO 80540, Lyons, United States of America (US)
2
- Name:
- Joseph, P. LYSSIKATOS
- Address:
- CO 80027, Superior, United States of America (US)
3
- Name:
- Brian, T. HURLEY
- Address:
- CO 80304, Boulder, United States of America (US)
4
- Name:
- Allison, L. MARLOW
- Address:
- CO 80304, Boulder, United States of America (US)
Licensee
- Name:
- Pierre Fabre Medicament
- From:
- 21/12/2017
- Address:
- 45 Place Abel Gance, 92100, Boulogne-Billancourt, France (FR)
- To:
Priority
- Priority Patent Number:
- 364007 P
- Priority Date:
- 13/03/2002
- Priority Country:
- United States of America (US)
Classification
- Main IPC Class:
- A61K 31/4184;
- IPC or IDT classification:
- A61P 35/00; C07D 235/04; C07D 235/06;
Publication
Bulletin
1
- Bulletin Heading:
- VRV
- Journal edition number:
- 11/23
- Publication date:
- 15/03/2023
- Description:
- Lapse or annulment
2
- Bulletin Heading:
- CO
- Journal edition number:
- 28/19
- Publication date:
- 10/07/2019
- Description:
- Changes in the Netherlands Patent Register
3
- Bulletin Heading:
- MED
- Journal edition number:
- 02/18
- Publication date:
- 03/01/2018
- Description:
- Other communications
4
- Bulletin Heading:
- CO
- Journal edition number:
- 42/16
- Publication date:
- 19/10/2016
- Description:
- Changes in the Netherlands Patent Register
5
- Bulletin Heading:
- EP4
- Journal edition number:
- 2010/03
- Publication date:
- 01/03/2010
- Description:
- European patents granted in amended form for the Netherlands
6
- Bulletin Heading:
- EP2
- Journal edition number:
- 2010/02
- Publication date:
- 01/02/2010
- Description:
- European patents granted for the Netherlands
European Patent Bulletin
- Issue number:
- 200948
- Publication date:
- 25/11/2009
- Description:
- Grant (B1)
Deed
Change of owner(s)
- Change Kind/ Decision Type:
- Change of owner(s) name
- Deed Number:
- RC201901285B
- Date Registered:
- 28/06/2019
- License Effective Date:
- License Expiration Date:
- Scope of License:
- Deed Filer:
- ir. H.A. Witmans c.s.
- Journal Edition Number:
- Text:
- Deed Status:
- Country Code:
- Updated License Number:
- Terminated License Number:
Added Owner(s)
1
- Name:
- AstraZeneca AB
- Address:
- Västra Mälarehamnen 9, 15185, Södertälje, Sweden (SE)
2
- Name:
- Array BioPharma Inc.
- Address:
- 3200 Walnut Street, 80301, Boulder, CO, United States of America (US)
Changed Pledgee
- Name:
- Address:
Removed Usufructuary
- Name:
- Address:
Added Usufructuary
- Name:
- Address:
Changed Usufructuary
- Name:
- Address:
Licence
- Change Kind/ Decision Type:
- New licence registration
- Deed Number:
- RC201702541A
- Date Registered:
- 21/12/2017
- License Effective Date:
- 21/12/2017
- License Expiration Date:
- Scope of License:
- Exclusive
- Deed Filer:
- ir. A.R. Aalbers
- Journal Edition Number:
- Text:
- Deed Status:
- Country Code:
- Updated License Number:
- Terminated License Number:
Added Licensee(s)
- Name:
- Pierre Fabre Medicament
- Address:
- 45 Place Abel Gance, 92100, Boulogne-Billancourt, France (FR)
Changed Pledgee
- Name:
- Address:
Removed Usufructuary
- Name:
- Address:
Added Usufructuary
- Name:
- Address:
Changed Usufructuary
- Name:
- Address:
Change of owner(s)
- Change Kind/ Decision Type:
- Assignment
- Deed Number:
- RC201602284A
- Date Registered:
- 20/09/2016
- License Effective Date:
- License Expiration Date:
- Scope of License:
- Deed Filer:
- ir. F.A. Geurts c.s.
- Journal Edition Number:
- Text:
- Deed Status:
- Country Code:
- Updated License Number:
- Terminated License Number:
Added Owner(s)
1
- Name:
- Array Biopharma, Inc.
- Address:
- 3200 Walnut Street, 80301, Boulder, Colorado, United States of America (US)
2
- Name:
- AstraZeneca AB
- Address:
- Västra Mälarehamnen 9, 15185, Södertälje, Sweden (SE)
Changed Pledgee
- Name:
- Address:
Removed Usufructuary
- Name:
- Address:
Added Usufructuary
- Name:
- Address:
Changed Usufructuary
- Name:
- Address:
Annual Fee
- Annual Fee(s) Due Date:
- Annual Fee Number:
- Last Annual Payment Date:
- 17/02/2022
- Last Annual Fee Paid Number:
- 20
- Last Annual Fee Paid Amount:
- 1400 Euro
- Payer:
- Master Data Center
| Filing date | Document type | Document Description | Number of pages | File Type | ||
|---|---|---|---|---|---|---|
| 28/12/2017 | Outgoing Correspondence | Letter registration deed | 1 | /8/4/1/4/1/0503714148/docs/ep03714148.8_1_184096l119.pdf | ||
| 21/12/2017 | Request for Change | First filed deed | 13 | /8/4/1/4/1/0503714148/docs/ep03714148.8_5_rfc20171221120653045.pdf | ||
| 17/10/2016 | Outgoing Correspondence | Letter registration deed | 1 | /8/4/1/4/1/0503714148/docs/ep03714148.8_6_90892l118.pdf | ||
| 20/09/2016 | Incoming Correspondence Paper | Accompanying letter incoming document | 2 | /8/4/1/4/1/0503714148/docs/ep03714148.8_0_incomingcorrespondencepaper20161013050955168.pdf | ||
| 20/09/2016 | Request for Change | First filed deed | 13 | /8/4/1/4/1/0503714148/docs/ep03714148.8_3_rfc20161013050955307.pdf | ||
| 13/01/2010 | Claims | Translated claims | 23 | /8/4/1/4/1/0503714148/docs/ep03714148.8_4_claims20100113.pdf | ||
| 10/11/2009 | Incoming Correspondence Paper | Other | 1 | /8/4/1/4/1/0503714148/docs/ep03714148.8_2_incomingcorrespondencepaper20091110.pdf |